First-trimester fetal sex determination in maternal serum using real-time PCR

• Published in: Prenatal diagnosis 2001-12, Vol.21 (12), p.1070-1074
• Main Authors: Costa, Jean-Marc, Benachi, Alexandra, Gautier, Evelyne, Jouannic, Jean-Marie, Ernault, Pauline, Dumez, Yves
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; DNA - blood; DNA-Binding Proteins - genetics; Female; fetal DNA; first-trimester pregnancy; Gynecology. Andrology. Obstetrics; Humans; Male; Management. Prenatal diagnosis; maternal blood; Medical sciences; Nuclear Proteins; Polymerase Chain Reaction - methods; Pregnancy; Pregnancy. Fetus. Placenta; real-time PCR; Sensitivity and Specificity; Sex Determination Analysis - methods; Sex-Determining Region Y Protein; Transcription Factors
• ISSN: 0197-3851; 1097-0223
• DOI: 10.1002/pd.219

An Erratum has been published for this article in Prenatal Diagnosis 22(13) 2002, 1241. Fetal sex prediction can be achieved using PCR targeted at the SRY gene by analysing cell‐free fetal DNA in maternal serum. Unfortunately, the results reported to date show a lack of sensitivity, especially during the first trimester of pregnancy. Therefore, determination of fetal sex by maternal serum analysis could not replace karyotype analysis following chorionic villus sampling. A new highly sensitive real‐time PCR was developped to detect an SRY gene sequence in maternal serum. Analysis was performed on 121 pregnant women during the first trimester of pregnancy (mean gestational age: 11.8 weeks). Among them, 51 had at least one previous male‐bearing pregnancy. Results were compared with fetal sex. SRY PCR analysis of maternal serum was in complete concordance with fetal sex. Among the 121 pregnant women, 61 were bearing a male fetus and 60 a female fetus. No false‐negative results were observed. Furthermore, no false‐positive results occurred, even though 27 women carrying a female fetus during the current pregnancy had at least one previous male‐bearing pregnancy. This study demonstrates that a reliable, non‐invasive sex determination can be achieved by PCR analysis of maternal serum during the first trimester of pregnancy. This non‐invasive approach for fetal sex prediction should have great implications in the management of pregnant women who are carriers of an X‐linked genetic disorder. Prenatal diagnosis might thus be performed for male fetuses only, avoiding invasive procedures and the risk of the loss of female fetuses. Copyright © 2001 John Wiley & Sons, Ltd.